The “Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology), by End User - Global Forecast to 2019”, report provides a detailed overview of the major drivers, restraints, opportunities, current market trends, and strategies impacting the global epigenetics market along with the estimates and forecasts of the revenue and market share analysis.
Dallas, TX -- (SBWIRE) -- 06/05/2015 -- Browse 80 market data tables with 119 figures spread through 200 pages and in-depth TOC on "Epigenetics Market"
Early buyers will receive 10% customization on this report.
The global epigenetics market was valued at an estimated $413.24 million in 2014. This market is expected to grow at a CAGR of 13.64% between 2014 and 2019 to reach $783.17 million in 2019.
The epigenetics market is segmented on the basis of products into enzymes; instruments and consumables; kits; and reagents. Each of these market segments is further divided into multiple product segments and sub-segments. The epigenetics enzymes market consists of three subsegments, namely, DNA-modifying enzymes; protein-modifying enzymes; and RNA-modifying enzymes. Of these, the DNA-modifying enzymes segment had the largest share of the epigenetics enzymes market in 2014 and is expected to grow at the highest CAGR between 2014 and 2019. The subsegments of the epigenetics instruments and consumables market are mass spectrometers; next-generation sequencers; qPCRs; sonicators; and other epigenetics instruments & consumables. Of these, the next-generation sequencers segment had the largest share of the epigenetics instruments and consumables market in 2014 and is expected to grow at the highest CAGR between 2014 and 2019.
Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=896
The subsegments of the epigenetics kits segments are bisulfite conversion kits; ChIP- seq kits; RNA sequencing kits; whole genome amplification kits; 5-hmC & 5-mC analysis kits; and other epigenetics kits. Of these, the ChIP- seq kits segment had the largest share in 2014. The whole genome amplification kits segment is expected to grow at the highest CAGR between 2014 and 2019. The epigenetics reagents market consists of six segments, namely, antibodies; buffers; histones; magnetic beads; primers; and other epigenetics reagents. Of these, the antibodies segment had the largest share of the epigenetics reagents market in 2014 and is expected to grow at the highest CAGR between 2014 and 2019.
The research areas included in this report are developmental biology, drug discovery, oncology and other research areas. The oncology research segment had the largest share of the epigenetics market in 2014, whereas the drug discovery segment is expected to grow at the highest CAGR between 2014 and 2019. The geographic segments included in this report are North America, Europe, Asia, and Rest of the World.
Increasing prevalence of cancer will be the most important growth driver for the epigenetics market. Furthermore, increased funding for epigenetics research, along with growing partnerships between biotechnology and pharmaceutical companies for the development of epigenetics-based products, will aid the growth of this market.
You can speak To Research Analyst to know more about Report:
Major players in the epigenetics market include Abcam (U.K.), Active Motif (U.S.), Diagenode (Belgium), EMD Millipore (U.S.), Illumina (U.S.), New England Biolabs (U.S.), QIAGEN (Netherlands), Sigma-Aldrich (U.S.), Thermo Fisher Scientific (U.S.), and Zymo Research (U.S.).
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets